Skip to main content

Zymaxid FDA Approval History

FDA Approved: Yes (First approved May 18, 2010)
Brand name: Zymaxid
Generic name: gatifloxacin
Dosage form: Ophthalmic Solution
Company: Allergan plc
Treatment for: Conjunctivitis, Bacterial

Zymaxid (gatifloxacin ophthalmic) is a fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.

Development timeline for Zymaxid

May 19, 2010Approval Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.